Product Information
SUBVENITE 200 MG TABLET is a generic product labeled by OWP Pharmaceuticals, Inc., priced at $0.0839 per EA under NDC 69102032001. Its NADAC has been published 410 times since Aug 22, 2018.
The High Outlier badge above means this manufacturer's average price in the LAMOTRIGINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
OWP Pharmaceuticals, Inc.NDC
69102032001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA078947On Market Since
3/10/2018
Pharmacological Classes
Price Statistics
The NADAC for SUBVENITE 200 MG TABLET has been published 410 times since Aug 22, 2018, and over the history we have for it it has risen 14.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0839 per EA |
|---|---|
| All-time high | $0.1026 (Jun 15, 2022) |
| All-time low | $0.0597 (Jul 17, 2024) |
| 52-week high | $0.0839 |
| 52-week low | $0.0787 |
| Median price | $0.0795 |
| Average price | $0.0815 |
| Largest weekly change | +53.2% (Aug 21, 2024) |
| Weeks tracked | 410 |
| Tracking since | Aug 22, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SUBVENITE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUBVENITE 200 MG TABLET, manufactured by OWP Pharmaceuticals, Inc., is $0.0839 per EA (NDC 69102032001), effective Jun 24, 2026.
How has the price of SUBVENITE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUBVENITE 200 MG TABLET has risen 14.2%. It has been tracked across 410 weekly CMS publications since Aug 22, 2018.
What are the highest and lowest recorded NADAC prices for SUBVENITE 200 MG TABLET?
Since Aug 22, 2018, the NADAC for SUBVENITE 200 MG TABLET has ranged from a low of $0.0597 (Jul 17, 2024) to a high of $0.1026 (Jun 15, 2022), with a median of $0.0795 per EA.
Are there cheaper alternatives to SUBVENITE 200 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as SUBVENITE 200 MG TABLET, but none are currently priced below it.
Who manufactures SUBVENITE 200 MG TABLET?
SUBVENITE 200 MG TABLET (NDC 69102032001) is labeled by OWP Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification